A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941
NCT01187186
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Liver Disease
Interventions
DRUG:
ASP1941
Sponsor
Astellas Pharma Inc